130 related articles for article (PubMed ID: 1688117)
1. Clinical findings. Abnormalities of the mental state and movement disorder and their correlates.
Johnstone EC; Owens DG; Frith CD; Leary J
Br J Psychiatry Suppl; 1991 Oct; (13):21-5, 44-6. PubMed ID: 1688117
[No Abstract] [Full Text] [Related]
2. Schizophrenia and severe tardive dyskinesia responsive to risperidone.
Kopala LC; Honer WG
J Clin Psychopharmacol; 1994 Dec; 14(6):430-1. PubMed ID: 7533794
[No Abstract] [Full Text] [Related]
3. [Schizophrenic deficit syndrome and neurologic tolerance].
Verdoux H; Bourgeois M
Encephale; 1996 Jun; 22 Spec No 2():45-7. PubMed ID: 8767042
[TBL] [Abstract][Full Text] [Related]
4. Negative symptoms, tardive dyskinesia and depression in chronic schizophrenia.
Barnes TR; Liddle PF; Curson DA; Patel M
Br J Psychiatry Suppl; 1989 Nov; (7):99-103. PubMed ID: 2575915
[No Abstract] [Full Text] [Related]
5. [Increased blink rate in schizophrenic patients].
Mackert A; Woyth C; Flechtner KM; Frick K
Nervenarzt; 1990 Jul; 61(7):426-30. PubMed ID: 1975431
[No Abstract] [Full Text] [Related]
6. [Treatment of schizophrenia from the viewpoint of the patient. Studies on the course of treatment and neuroleptic treatment from a personal perspective].
Windgassen K
Monogr Gesamtgeb Psychiatr Psychiatry Ser; 1989; 58():1-169. PubMed ID: 2576099
[No Abstract] [Full Text] [Related]
7. [Comparison of 2 depression scales and their relationship with negative and akinetic symptoms in stabilized schizophrenic patients].
Langlois-Thery S; Dollfus S; Lesieur P; Petit M
Encephale; 1994; 20(5):487-93. PubMed ID: 7828511
[TBL] [Abstract][Full Text] [Related]
8. [Exacerbation of catatonic symptoms in neuroleptic therapy].
Bräunig P; Krüger S; Höffler J
Nervenarzt; 1995 May; 66(5):379-82. PubMed ID: 7609820
[TBL] [Abstract][Full Text] [Related]
9. Association of negative symptoms with tardive dyskinesia in schizophrenic patients.
Chiu H; Lau J; Lam L; Shum P
Aust N Z J Psychiatry; 1993 Jun; 27(2):228-32. PubMed ID: 8103320
[TBL] [Abstract][Full Text] [Related]
10. ICI 204,636: a new atypical antipsychotic drug.
Hirsch SR; Link CG; Goldstein JM; Arvanitis LA
Br J Psychiatry Suppl; 1996 May; (29):45-56. PubMed ID: 8733823
[No Abstract] [Full Text] [Related]
11. [Schizophrenic patients in ambulatory treatment of a psychiatric hospital and in general practice of established psychiatrists].
Kaiser W; Isermann-Gerke M; Linden M; Wilms HU
Nervenarzt; 1991 Mar; 62(3):158-64. PubMed ID: 1675771
[TBL] [Abstract][Full Text] [Related]
12. Clozapine treatment of psychosis in patients with tardive dystonia: report of three cases.
Friedman JH
Mov Disord; 1994 May; 9(3):321-4. PubMed ID: 7913739
[TBL] [Abstract][Full Text] [Related]
13. Implications for the pharmacotherapy of schizophrenia.
Rep Group Adv Psychiatry; 1992; (134):35-58. PubMed ID: 1348372
[No Abstract] [Full Text] [Related]
14. Neuroleptic withdrawal in patients meeting criteria for supersensitivity psychosis.
Singh H; Hunt JI; Vitiello B; Simpson GM
J Clin Psychiatry; 1990 Aug; 51(8):319-21. PubMed ID: 1974249
[TBL] [Abstract][Full Text] [Related]
15. Neuroleptic-induced emesis: a new indication for clozapine?
Bustillo JR; Buchanan RW
Biol Psychiatry; 1995 Aug; 38(3):194-5. PubMed ID: 7578665
[No Abstract] [Full Text] [Related]
16. Movement disorders and psychological tests of frontal lobe function in schizophrenic patients.
Brown KW; White T; Palmer D
Psychol Med; 1992 Feb; 22(1):69-77. PubMed ID: 1349440
[TBL] [Abstract][Full Text] [Related]
17. Effects of verapamil on tardive dyskinesia and psychosis in schizophrenic patients.
Reiter S; Adler L; Angrist B; Peselow E; Rotrosen J
J Clin Psychiatry; 1989 Jan; 50(1):26-7. PubMed ID: 2562952
[TBL] [Abstract][Full Text] [Related]
18. Changes in symptoms and plasma homovanillic acid with amantadine hydrochloride in chronic schizophrenia.
Yamada K; Kanba S; Ohnishi K; Ashikari I; Yagi G; Asai M
Biol Psychiatry; 1997 May; 41(10):1062-4. PubMed ID: 9129786
[No Abstract] [Full Text] [Related]
19. Tardive dyskinesia and positive symptoms of schizophrenia.
White T; Brown KW; Woods JP
Acta Psychiatr Scand; 1991 May; 83(5):377-9. PubMed ID: 1677232
[TBL] [Abstract][Full Text] [Related]
20. Predictors of subjective and objective quality of life in outpatients with schizophrenia.
Yamauchi K; Aki H; Tomotake M; Iga J; Numata S; Motoki I; Izaki Y; Tayoshi S; Kinouchi S; Sumitani S; Tayoshi S; Takikawa Y; Kaneda Y; Taniguchi T; Ishimoto Y; Ueno S; Ohmori T
Psychiatry Clin Neurosci; 2008 Aug; 62(4):404-11. PubMed ID: 18778437
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]